Search results
Results from the WOW.Com Content Network
Pfizer cross-appealed denial of its motion to dismiss pursuant to Rule 12(b)(6) of the Federal Rules of Civil Procedure. The Court of Appeals reviewed the forum non conveniens dismissal under the "clear abuse of discretion" standard. [citation needed] The Court of Appeals, however, revisited the Court's analysis of the adequate alternative ...
The following is a list of the 20 largest settlements reached between the United States Department of Justice and pharmaceutical companies from 2001 to 2013, ordered by the size of the total settlement. The settlement amount includes both the civil (False Claims Act) settlement and criminal fine.
The following is a list of the 21 largest civil settlements, reached between the United States Department of Justice and pharmaceutical companies from 2001 to 2017, ordered by the size of the total civil settlement. Some of these matters also resolved criminal fines and penalties, listed in parentheses, but these amounts are not considered when ...
(Reuters) -A federal judge on Monday dismissed a lawsuit by a major pharmaceutical industry trade association challenging a new program that allows Medicare to negotiate prices with drug companies ...
This alphabetical list contains 634 people whose deaths can be reliably sourced to be the result of drug overdose or acute drug intoxication. Where sources indicate drug overdose or intoxication was only suspected to be the cause of death, this will be specified in the 'notes' column.
Nov. 13—A Westmoreland County judge on Monday dismissed criminal charges against a Southwest Greensburg woman who prosecutors said was responsible for the fatal overdose of her live-in boyfriend ...
Disney has now dropped its effort to get a wrongful death lawsuit dismissed over the fine print in its Disney+ streaming app. The company had previously said its terms include an arbitration clause.
The following are settlements reached with US authorities against pharmaceutical companies to resolve allegations of "off-label" promotion of drugs. Under the Federal Food, Drug, and Cosmetic Act, it is illegal for pharmaceutical companies to promote their products for uses not approved by the Food and Drug Administration (FDA), and corporations that market drugs for off-label indications may ...